Oneness Biotech Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.012x

Oneness Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Oneness Biotech Co Ltd (4743) has a cash flow conversion efficiency ratio of -0.012x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-120.08 Million ≈ $-3.78 Million USD) by net assets (NT$10.39 Billion ≈ $327.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Oneness Biotech Co Ltd (2009–2025)

Cash flow conversion efficiency of Oneness Biotech Co Ltd from 2009 to 2025. This chart illustrates how Oneness Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 4743 share price today for real-time trading data and today's change.

Oneness Biotech Co Ltd Cash Flow Conversion Ratio Explained

Oneness Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Oneness Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oneness Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see Oneness Biotech Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
JBG SMITH Properties NYSE:JBGS	0.002x
Beijing E Hualu Info Tech SHE:300212	-0.019x
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited STU:2TZ	-0.009x
Jiangsu Zhenjiang New Energy Equipment Co Ltd Class A SHG:603507	-0.026x
Sapphire Foods India Limited NSE:SAPPHIRE	0.153x
Zhongsheng Group Holdings Limited F:5Z0	0.040x
Arctech Solar Holding Co Ltd SHG:688408	0.074x
Guangdong Champion Asia Electronics Co Ltd SHG:603386	0.061x

Annual Cash Flow Conversion Efficiency for Oneness Biotech Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Oneness Biotech Co Ltd from 2009 to 2025. Review 4743 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$10.48 Billion ≈ $330.09 Million	NT$-460.24 Million ≈ $-14.50 Million	-0.044x	-62.71%
2024-12-31	NT$12.80 Billion ≈ $403.27 Million	NT$-345.58 Million ≈ $-10.89 Million	-0.027x	+0.94%
2023-12-31	NT$14.50 Billion ≈ $456.74 Million	NT$-395.13 Million ≈ $-12.45 Million	-0.027x	+53.97%
2022-12-31	NT$14.88 Billion ≈ $468.80 Million	NT$-881.00 Million ≈ $-27.76 Million	-0.059x	-188.75%
2021-12-31	NT$14.09 Billion ≈ $443.89 Million	NT$-288.89 Million ≈ $-9.10 Million	-0.021x	-278.41%
2020-12-31	NT$13.76 Billion ≈ $433.50 Million	NT$158.14 Million ≈ $4.98 Million	0.011x	+134.81%
2019-12-31	NT$6.46 Billion ≈ $203.48 Million	NT$-213.25 Million ≈ $-6.72 Million	-0.033x	-1295.85%
2018-12-31	NT$2.17 Billion ≈ $68.23 Million	NT$-5.12 Million ≈ $-161.40K	-0.002x	+96.43%
2017-12-31	NT$2.49 Billion ≈ $78.60 Million	NT$-165.27 Million ≈ $-5.21 Million	-0.066x	-54.05%
2016-12-31	NT$2.52 Billion ≈ $79.53 Million	NT$-108.54 Million ≈ $-3.42 Million	-0.043x	+16.46%
2015-12-31	NT$2.77 Billion ≈ $87.13 Million	NT$-142.34 Million ≈ $-4.48 Million	-0.051x	+34.05%
2014-12-31	NT$1.93 Billion ≈ $60.95 Million	NT$-150.98 Million ≈ $-4.76 Million	-0.078x	-71.90%
2013-12-31	NT$1.97 Billion ≈ $61.94 Million	NT$-89.26 Million ≈ $-2.81 Million	-0.045x	-364.04%
2012-12-31	NT$1.40 Billion ≈ $44.26 Million	NT$24.15 Million ≈ $760.95K	0.017x	+180.32%
2011-12-31	NT$1.37 Billion ≈ $43.07 Million	NT$-29.27 Million ≈ $-922.04K	-0.021x	-115.21%
2010-12-31	NT$1.09 Billion ≈ $34.31 Million	NT$153.25 Million ≈ $4.83 Million	0.141x	+252.19%
2009-12-31	NT$1.11 Billion ≈ $34.86 Million	NT$-102.30 Million ≈ $-3.22 Million	-0.092x	--

About Oneness Biotech Co Ltd

TWO:4743 Taiwan Biotechnology

Market Cap

$691.90 Million

NT$21.96 Billion TWD

Market Cap Rank

#10256 Global

#362 in Taiwan

Share Price

NT$45.80

Change (1 day)

-2.55%

52-Week Range

NT$41.15 - NT$74.80

All Time High

NT$395.32